These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26042389)

  • 1. Antimicrobial interactions: mechanisms and implications for drug discovery and resistance evolution.
    Bollenbach T
    Curr Opin Microbiol; 2015 Oct; 27():1-9. PubMed ID: 26042389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic discovery of drug interaction mechanisms.
    Chevereau G; Bollenbach T
    Mol Syst Biol; 2015 Apr; 11(4):807. PubMed ID: 25924924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug interactions modulate the potential for evolution of resistance.
    Michel JB; Yeh PJ; Chait R; Moellering RC; Kishony R
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):14918-23. PubMed ID: 18815368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The physiology and genetics of bacterial responses to antibiotic combinations.
    Roemhild R; Bollenbach T; Andersson DI
    Nat Rev Microbiol; 2022 Aug; 20(8):478-490. PubMed ID: 35241807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neighbor communities in drug combination networks characterize synergistic effect.
    Zou J; Ji P; Zhao YL; Li LL; Wei YQ; Chen YZ; Yang SY
    Mol Biosyst; 2012 Oct; 8(12):3185-96. PubMed ID: 23014807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When more is less: Emergent suppressive interactions in three-drug combinations.
    Beppler C; Tekin E; White C; Mao Z; Miller JH; Damoiseaux R; Savage VM; Yeh PJ
    BMC Microbiol; 2017 May; 17(1):107. PubMed ID: 28477626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of antibiotic resistance: insight into the roles of molecular mechanisms of resistance and treatment context.
    Maclean RC; Hall AR; Perron GG; Buckling A
    Discov Med; 2010 Aug; 10(51):112-8. PubMed ID: 20807471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant strategies for potentiation of antibiotics to overcome antimicrobial resistance.
    Pieren M; Tigges M
    Curr Opin Pharmacol; 2012 Oct; 12(5):551-5. PubMed ID: 22835931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics-Driven Exploration of the Chemical Drug Space to Predict Combination Antimicrobial Therapies.
    Campos AI; Zampieri M
    Mol Cell; 2019 Jun; 74(6):1291-1303.e6. PubMed ID: 31047795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bacterial resistance and study of new antibiotics].
    Xiao CL; Yao TJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):351-3. PubMed ID: 15379254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance drives antibacterial drug development.
    Theuretzbacher U
    Curr Opin Pharmacol; 2011 Oct; 11(5):433-8. PubMed ID: 21862408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced identification of synergistic and antagonistic emergent interactions among three or more drugs.
    Tekin E; Beppler C; White C; Mao Z; Savage VM; Yeh PJ
    J R Soc Interface; 2016 Jun; 13(119):. PubMed ID: 27278366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel systemic antibiotics in dermatology.
    Atanaskova Mesinkovska N; Tomecki KJ
    Dermatol Ther; 2012; 25(1):1-5. PubMed ID: 22591494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting current understanding of antibiotic action for discovery of new drugs.
    Chopra I; Hesse L; O'Neill AJ
    Symp Ser Soc Appl Microbiol; 2002; (31):4S-15S. PubMed ID: 12481824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic insights into intrinsic and acquired drug resistance mechanisms in Achromobacter xylosoxidans.
    Hu Y; Zhu Y; Ma Y; Liu F; Lu N; Yang X; Luan C; Yi Y; Zhu B
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1152-61. PubMed ID: 25487802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A need for new generation antibiotics against MRSA resistant bacteria.
    Pasberg-Gauhl C
    Drug Discov Today Technol; 2014 Mar; 11():109-16. PubMed ID: 24847660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic interactions in two-drug and three-drug combinations (thymol, EDTA and vancomycin) against multi drug resistant bacteria including E. coli.
    Hamoud R; Zimmermann S; Reichling J; Wink M
    Phytomedicine; 2014 Mar; 21(4):443-7. PubMed ID: 24262063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting antibiotic resistance.
    Martínez JL; Baquero F; Andersson DI
    Nat Rev Microbiol; 2007 Dec; 5(12):958-65. PubMed ID: 18007678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.
    El Zowalaty ME; Al Thani AA; Webster TJ; El Zowalaty AE; Schweizer HP; Nasrallah GK; Marei HE; Ashour HM
    Future Microbiol; 2015; 10(10):1683-706. PubMed ID: 26439366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.